Studies have also shown that the expression of PD‐L1 protein (encoded by the CD274 gene) in tumor cells has been proposed as a predictive biomarker of response to anti‐PD‐1/PD‐L1 treatment [39, 40, 41]. This evidence concerns the gene PDCD1 and neoplasm.